NCT07117331Completed
Technology-Enhanced Continuous Nursing System (TECNS) for Post-CABG Recovery
Efficacy of a Technology-Enhanced Continuous Nursing Intervention on Clinical Outcomes and Quality of Life Following Coronary Artery Bypass Grafting: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 12 Aug 2025
Brief summary (registry, in English)
This is a prospective, randomized controlled trial to evaluate the effectiveness of a Technology-Enhanced Continuous Nursing System (TECNS) compared to routine care for patients after coronary artery bypass grafting (CABG). The study aims to determine if the TECNS intervention, which includes digital health tools, personalized tele-rehabilitation, and continuous nursing support, can improve clinical outcomes such as postoperative hemoglobin recovery, reduce long-term major adverse cardiac events (MACE), and enhance patients' quality of life and psychological well-being.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 358 (actual)
- First submitted
- 30 Jul 2025
- Start date
- 1 Jan 2018
- Primary completion date
- 30 Jun 2025
- Lead sponsor
- The First Hospital of Hebei Medical University
- Diseases
- Coronary artery disease
- NCT number
- NCT07117331
What you commit to
- Study type: Interventional
- Participants enrolled: 358
- From 1 Jan 2018 to the primary completion date, 30 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe coexisting conditions that could confound outcomes (e.g., end-stage renal disease, severe COPD \[GOLD stage IV\], active malignancy)
- Severe cognitive impairment or psychiatric disorders precluding informed consent or adherence to the protocol
Lab values
- Left ventricular ejection fraction \< 30%
Other
- Emergency or salvage CABG
- Participation in other clinical trials
Who the study is looking for
- Age between 18 and 75 years
- Meeting diagnostic criteria for elective CABG
- Able to provide informed consent
- Owned a smartphone and was willing to use it for the study intervention
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The First Hospital of Hebei Medical University Coordinator of this site? Confirm its status | Shijiazhuang | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.